Atrioventricular septal defect with separate right and left atrioventricular valvar orifices in a patient with foetal hydantoin syndrome

Cardiology in the Young

Volumn 9, Issue 1, 1999, Pages 73-74

  Grech, Victor ^a   Vella, Cecil ^a  

^a ST LUKE S HOSPITAL   (Malta)

Author keywords

Anticonvulsants adverse effects; Foetal diseases chemically induced; Heart defects congenital, endocardial cushion defects

Indexed keywords

ANTICONVULSIVE AGENT; PHENYTOIN;

ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; CONGENITAL MALFORMATION; DOPPLER ECHOCARDIOGRAPHY; EPILEPSY; FEMALE; FETOMATERNAL TRANSFUSION; FETUS DISEASE; FOLLOW UP; HEART CATHETERIZATION; HEART SEPTUM DEFECT; HUMAN; MALE; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY COMPLICATION; SYNDROME;

ABNORMALITIES, DRUG-INDUCED; ANTICONVULSANTS; ECHOCARDIOGRAPHY, DOPPLER; EPILEPSY; FEMALE; FETAL DISEASES; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HEART SEPTAL DEFECTS, ATRIAL; HEART SEPTAL DEFECTS, VENTRICULAR; HUMANS; INFANT, NEWBORN; MALE; MATERNAL-FETAL EXCHANGE; PHENYTOIN; PREGNANCY; PREGNANCY COMPLICATIONS; SYNDROME;

EID: 0032602698     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1047951100007447     Document Type: Article

References (10)

1. Gilman AG, Rail TW, Nies AS, Taylor P. The Pharmacologic Basis of Therapeutics. McGraw-Hill, New York, 1990.
2. Meadow SR. Anticonvulsant drugs and congenital abnormalities. Lancet 1968; ii: 1296.
3. Fedrick J. Epilepsy and pregnancy: a report from the Oxford Record Linkage Study. Br Med J 1973; 2: 442-448.
4. Monson RR, Rosenbery L, Hartz SC, Saphiro S, Heinonen OP, Slone D. Diphenylhydantoin and selected congenital malformations. N Engl J Med 1973; 289: 1049-1052.
5. Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the foetus and newborn. Lancet 1972; ii: 839-843.
6. American Academy of Pediatrics Committee on Drugs. Anticonvulsants and pregnancy. Pediatrics 1979; 63: 331-333.
7. Hanson JW, Myrianthopoulos NC, Sedgwick Harvey MA, Smith DW. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the foetal hydantoin syndrome. J Pediatr 1976; 89: 662-668.
8. Buehler BA, Delimont D, van Waes M, Finnell RH. Prenatal prediction of risk of the foetal hydantoin syndrome. N Engl J Med 1990; 322: 1567-1572.
9. Fedrick J. Epilepsy and pregnancy. Br Med J 1973; 2: 442-448.
10. Bartoshesky LE, Bhan I, Nagpaul K, Pashayan H. Severe cardiac and ophthalmologic malformations in an infant exposed to diphenylhydantoin in utero. Pediatrics 1982; 69: 202-203.